Roivant Sciences Ltd.

Drug discovery platform working across several therapeutic areas and indications through a hub-and-spoke system of independently managed and funded "vants"

Roivant Sciences is a unique biopharmaceutical firm dedicated to realizing the full value of promising drug candidates by advancing them from late-stage clinical development to commercialization. Backed by a global multi-strategy investment firm and a global drug manufacturer, Roivant Sciences has both the capital and the in-house drug development expertise to move programs forward across a variety of pharmaceutical indications. Roivant Sciences will selectively evaluate regional or global opportunities across all therapeutic areas, mechanisms of action and routes of administration, with a special emphasis on areas of high unmet medical need, including rare diseases. The company will consider all levels of innovativeness as they seek to identify drug candidates whose potential may be underappreciated.